Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
12,336 GBX | +0.75% |
|
+1.87% | +16.28% |
17/07 | AstraZeneca's Capivasertib Gets UK Marketing Authorization for Advanced Breast Cancer Treatment | MT |
17/07 | EU court criticizes Commission over handling of COVID vaccine contracts | RE |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+16.28% | 25TCr | |
+55.35% | 82TCr | |
+32.16% | 60TCr | |
-0.10% | 38TCr | |
+15.47% | 32TCr | |
+13.10% | 31TCr | |
+12.84% | 25TCr | |
+16.54% | 18TCr | |
+4.31% | 17TCr | |
+3.10% | 13TCr |
- Stock Market
- Equities
- AZN Stock
- News AstraZeneca PLC
- London Shares Outpace European Peers Amid Muted Trading, China Reopening Jitters